Authors: Holman, WL Ormaza, S Seemuth, K Boehmer, JP Richenbacher, WE

Citation: Wl. Holman et al., How to run an outpatient VAD program: Overview, ASAIO J, 47(6), 2001, pp. 588-589

Authors: Grady, KL Meyer, P Mattea, A White-Williams, C Ormaza, S Kaan, A Todd, B Chillcott, S Dressler, D Fu, A Piccione, W Costanzo, MR

Citation: Kl. Grady et al., Improvement in quality of life outcomes 2 weeks after left ventricular assist device implantation, J HEART LUN, 20(6), 2001, pp. 657-669

Authors: Jackson, A Palmer, S Davis, RD Pappendick, A Pearson, E Savik, K Ormaza, S Hertz, M Dacey, M Miller, L Reinsmoen, NL

Citation: A. Jackson et al., Cytokine genotypes in kidney, heart, and lung recipients: Consequences foracute and chronic rejection, TRANSPLAN P, 33(1-2), 2001, pp. 489-490

Authors: Park, SJ Nguyen, DQ Bank, AJ Ormaza, S Bolman, RM

Citation: Sj. Park et al., Left ventricular assist device bridge therapy for acute myocardial infarction, ANN THORAC, 69(4), 2000, pp. 1146-1151

Authors: Reinsmoen, NL Jackson, A Hertz, M Savik, K Kubo, S Ormaza, S Miller, L McSherry, C

Citation: Nl. Reinsmoen et al., Peripheral blood allogeneic microchimerism in lung and cardiac allograft recipients, J LEUK BIOL, 66(2), 1999, pp. 306-309